These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15474140)

  • 1. Attributable testing for abnormal prion protein, database linkage, and blood-borne vCJD risks.
    Bird SM
    Lancet; 2004 Oct 9-15; 364(9442):1362-4. PubMed ID: 15474140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
    Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J
    Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.
    Gillies M; Chohan G; Llewelyn CA; MacKenzie J; Ward HJ; Hewitt PE; Will RG
    Vox Sang; 2009 Oct; 97(3):211-8. PubMed ID: 19671123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion infectivity in variant Creutzfeldt-Jakob disease rectum.
    Wadsworth JD; Joiner S; Fox K; Linehan JM; Desbruslais M; Brandner S; Asante EA; Collinge J
    Gut; 2007 Jan; 56(1):90-4. PubMed ID: 16763054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.
    Hilton DA; Ghani AC; Conyers L; Edwards P; McCardle L; Ritchie D; Penney M; Hegazy D; Ironside JW
    J Pathol; 2004 Jul; 203(3):733-9. PubMed ID: 15221931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study.
    Wadsworth JD; Dalmau-Mena I; Joiner S; Linehan JM; O'Malley C; Powell C; Brandner S; Asante EA; Ironside JW; Hilton DA; Collinge J
    J Pathol; 2011 Mar; 223(4):511-8. PubMed ID: 21294124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented?
    Vamvakas EC
    Transfus Med Rev; 2011 Apr; 25(2):133-44. PubMed ID: 21345641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies.
    Belondrade M; Nicot S; Béringue V; Coste J; Lehmann S; Bougard D
    PLoS One; 2016; 11(1):e0146833. PubMed ID: 26800081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Peden AH; Ritchie DL; Ironside JW
    Folia Neuropathol; 2005; 43(4):271-8. PubMed ID: 16416391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.
    Wroe SJ; Pal S; Siddique D; Hyare H; Macfarlane R; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Hewitt P; Collinge J
    Lancet; 2006 Dec; 368(9552):2061-7. PubMed ID: 17161728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should deceased donors be tested for vCJD?
    Warwick RM; Eglin R
    Cell Tissue Bank; 2005; 6(4):263-70. PubMed ID: 16308765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.
    Mead S; Wadsworth JD; Porter MC; Linehan JM; Pietkiewicz W; Jackson GS; Brandner S; Collinge J
    JAMA Neurol; 2014 Mar; 71(3):340-3. PubMed ID: 24445428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update.
    Lescoutra-Etchegaray N; Jaffré N; Sumian C; Durand V; Correia E; Mikol J; Luccantoni-Freire S; Culeux A; Deslys JP; Comoy EE
    Transfusion; 2015 Jun; 55(6):1231-41. PubMed ID: 25647476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment.
    Sachse C; Groschup MH; Warzok R; Greinacher A
    Eur J Haematol; 2003 Jan; 70(1):11-6. PubMed ID: 12631254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US.
    Ponte ML
    PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
    Dabaghian RH; Barnard G; McConnell I; Clewley JP
    J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variant Creutzfeld-Jakob disease (vCJD) : Epidemiology and prevention from human to human secondary transmission].
    Beekes M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):597-605. PubMed ID: 20449549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.